 |
Rudolf Jaenisch, MD
 |
 Member, Whitehead Institute
Professor of Biology, MIT
617.258.5186 phone
617.258.6505 fax
kemske@wi.mit.edu |
|
June 6 — Jaenisch lab has manipulated
mouse fibroblasts and turned them into cells
with such developmental elasticity that they
appear identical to embryonic stem cells.
Read more >
|
Rudolf Jaenisch is a Founding Member of Whitehead
Institute and a pioneer of transgenic science, in which
researchers alter an animal’s genetic makeup
to produce a variant of a human disease. Jaenisch has
focused on creating transgenic mice that enable his
lab to study forms of cancer and neurological diseases
that have long baffled researchers.
Selected Achievements
• Created the first transgenic animal model
• First experiment showing that therapeutic
cloning could correct genetic defects in mice
• 1996 Boehringer Mannheim Molecular Bioanalytics
Prize
• 2001 First Peter Gruber Foundation Award
in Genetics
• 2002 Robert Koch Prize for Excellence in
Scientific Achievement
• Member, National Academy of Sciences
• Member, Institute of Medicine
• Fellow, American Academy of Arts and Sciences |
Jaenisch’s first breakthrough
occurred in the 1970s when he demonstrated for the first
time that foreign DNA could be integrated into the DNA
of early mouse embryos; mice derived from these embryos
carried the foreign genes in all of their tissues. Subsequently,
Jaenisch injected retrovirus into early mouse embryos
and showed that leukemia DNA sequences had integrated
not only into the mouse genome but also to its offspring.
These mice were the first transgenic animals in history.
Jaenisch also is a leader in the field of therapeutic
cloning, also called nuclear transfer, in which the
genetic information from one cell is transplanted into
an unfertilized egg from which DNA has been removed.
When placed in a Petri dish, this egg develops into
a blastocyst from which stem cells can be taken. Jaenisch’s
therapeutic cloning research occurs exclusively with
mice, but he advocates using the same techniques with
human cells so that we may one day develop therapies
for diseases that are currently untreatable. [
therapeutic cloning 220 kbps QuickTime] Conversely,
Jaenisch opposes human reproductive cloning, in which
the egg is placed not in a Petri dish but into the uterus
of a female, in the hope that it will develop into a
fetus. [
reproductive cloning 220 kbps QuickTime]
Recently, using mice as a model, Jaenisch demonstrated
that it is possible to procure embryonic stem cells
without harming a viable embryo. Using a technique called
"altered nuclear transfer," Jaenisch created an embryo-like
entity that was genetically incapable of implanting
in a uterus, and that also had certain structural deficiencies.
Although this entity was not a viable embryo, it did
yield perfectly healthy embryonic stem cells. If this
research is successfully repeated in human cells, it
might provide a solution to the ethical debate.
Today, the over-arching
goal of Jaenisch’s lab
is to understand what scientists call epigenetic regulation
of gene expression. This refers to the biological mechanisms
that affect how genetic information is converted into
cell structures but that don’t alter the genes
in the process. Jaenisch’s lab is also investigating
epigenetic mechanisms for certain types of cancer and
for brain development, where much of his work focuses
on how conditions such as Rett Syndrome occur.
Jaenisch received his doctorate in medicine from the
University of Munich in 1967. Before coming to Whitehead,
he was head of the Department of Tumor Virology at the
Heinrich Pette Institute at the University of Hamburg.
He has coauthored more than 300 research papers and
has received numerous prizes and recognitions including
an appointment to the National Academy of Sciences in
2003.
Selected Publications
Meissner, A., Jaenisch, R. (2005) Generation of
nuclear transfer-derived pluripotent ES cells from cloned
Cdx2-deficient blastocysts. Nature, October 16,
2005, early online edition.
Eggan K, Baldwin K, Tackett M, Osborne J, Gogos J,
Chess A, Axel R, Jaenisch R. (2004). Mice cloned
from olfactory sensory neurons. Nature. 428(6978):44-9.
Hochedlinger, K. & Jaenisch, R. (2002). Generation
of monoclonal mice by nuclear transfer from mature B
and T donor cells. Nature 415, 1035-1038.
Rideout, W.M., Hochedlinger, K., Kyba, M., Daley, G.,
& Jaenisch, R. (2002). Correction of a genetic
defect by nuclear transfer and combined cell and gene
therapy. Cell 109, 17-27.
Schnieke, A., Harbers, K., Jaenisch, R. (1983). Embryonic
lethal mutation in mice induced by retrovirus insertion
into the _1(I) collagen gene. Nature 304, 315-320.
Jaenisch, R., Jähner, D., Nobis, P., Simon, I.,
Löhler, J., Harbers, K., Grotkopp, D. (1981). Chromosomal
position and activation of retroviral genomes inserted
into the germ line of mice. Cell 24, 519-529.
Jaenisch, R. (1976). Germ line integration and
Mendelian transmission of the exogenous Moloney leukemia
virus. Proc. Natl. Acad. Sci. USA 73, 1260-1264.
Jaenisch, R., Mintz, B. (1974). Simian virus 40
DNA sequences in DNA of healthy adult mice derived from
preimplantation blastocysts injected with viral DNA.
Proc. Natl. Acad. Sci. USA 71, 1250-1254.
[research summary]
[publications
(pubmed database)] |
 |